The open index of psychedelic research

Esketamine multi-omic biomarker evaluation in major depressive disorder (EMBER-MDD): concept, objectives and methodologies of a non-clinical investigator-initiated study.

Hohoff C, Lange T, Steinbach L +3

The Effects of Midazolam, Dexmedetomidine, and Esketamine on Bispectral Index and Raw Electroencephalogram in Patients Under Propofol-Remifentanil Baseline Anesthesia

Comparative evaluation of ease in dental treatment using midazolam versus midazolam-ketamine in uncooperative children.

Sharma V, Majreti S, Agarwal N +5

Linagliptin, a Selective DPP-4 Inhibitor, Attenuates Ketamine- and Diazepam-Induced Deficits in Passive Avoidance Performance in Mice.

Fronc K, Listos P, Kasprzak P +9

No evidence for direct physical interaction of 5-HT _2A -mGluR2 receptors <i>in vitro</i> or <i>in vivo</i>

Fordyce BA, Chiu Y, Wright NJ +8

Patient-centred education for ketamine and esketamine therapies in mood disorders.

Kachlik Z, Cubała WJ, Walaszek M

Ketamine-Butorphanol-Azaperone-Medetomidine for Helicopter Capture of Free-Ranging Caribou (Rangifer tarandus) in Alaska, USA.

Roug A, Hunter A, Jamison M +2

Readability of informed consent forms from ClinicalTrials.gov in ketamine clinical trials for mental health conditions: a cross-sectional analysis.

Swieczkowski D, Kwaśny A, Cubała WJ

Psychedelics and Metacognition

Influence of physiological and pharmacological factors on conducted electrical device safety thresholds.

Deakin CD

Classical psychedelic microdosing, mood, and cognitive function: An umbrella review with narrative synthesis.

Özaydın Y, Canlan Özaydın B

Supporting Data and Regulatory Analysis Tools for the Assessment of Psychedelic Clinical Trials

Swieczkowski, Damian

Psilocybin reduces fear memory and restores neuroplasticity in the hippocampus and medial prefrontal cortex.

Du Y, Zhao X, Yao Y +3

Alterations in glutamatergic and GABAergic signaling in ketamine-induced neurotoxicity: mangiferin mitigates neurochemical, oxidative, and astrocytic dysregulation in the rat temporal-frontal cortex.

Anyanwu GE, Chukwu VO, Nto NJ +2

Psychedelic Integration and Subjectivity: A Critical Scoping Review Protocol of Governance and Meaning Making Across Diverse Institutional and Cultural Logics

Templated from Sexual identity moderation of associations between lifetime MDMA/ecstasy and psilocybin use and mental health outcomes in NSDUH 2015–2019

Impact of ketamine on cognitive function in major depressive disorder patients: A Review Across Formulations and Routes of Administration

Ergot Alkaloids Affect Foraging Activity of the Slime Mold &lt;i&gt;Physarum polycephalum&lt;/i&gt;.

Sexstone JR, Jones AM, Panaccione DG

Challenges in the interpretation of amphetamine results: differences of reactivity between immunoassay and immunochromatography.

Sainz-Pastor N, Martín E, Julià E +5

Evaluation of intravenous sedation in dental implant surgeries: A prospective cohort study.

Liu X, Cai Z, Chen C +7

The purpose of the psychosocial protocol in the psychedelic-assisted therapy: A scoping review.

Giaffone de Paiva Ferreira F, Fernandes JAB, Filev R +2

U.S. Psychedelic Use and Microdosing in 2025: Insights from a Probability-Based and Nationally Representative Survey.

Priest M, Kilmer B, Senator B +1

Management of Phantom Limb Pain Following Amputation in Pediatrics.

Kwok JG, Shick TJ, Dunton L +1

Safety, Efficacy, and Blinding Integrity of Psilocybin-Assisted Therapy for Substance Use Disorders: A Systematic Review of Randomized Controlled Trials